Holen Sie sich die Stockscreener-App
1.77
0.00%
0.00
Handel nachbörslich:
1.74
-0.03
-1.69%
Schlusskurs vom Vortag:
$1.77
Offen:
$1.74
24-Stunden-Volumen:
2.59M
Relative Volume:
0.81
Marktkapitalisierung:
$254.26M
Einnahmen:
$288.95M
Nettoeinkommen (Verlust:
$-119.03M
KGV:
-1.9656
EPS:
-0.9005
Netto-Cashflow:
$60.67M
1W Leistung:
+0.00%
1M Leistung:
-21.85%
6M Leistung:
-79.18%
1J Leistung:
-75.75%
1-Tages-Spanne:
$1.70
$1.79
1-Wochen-Bereich:
$1.665
$1.79
52-Wochen-Spanne:
$1.665
$11.55
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Firmenname
Maravai Lifesciences Holdings Inc
Sektor
Branche
Telefon
(858) 546-0004
Adresse
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Vergleichen Sie MRVI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
1.77 | 254.26M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-26 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Neutral |
| 2024-12-05 | Herabstufung | Goldman | Neutral → Sell |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-08 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-04-10 | Eingeleitet | Craig Hallum | Buy |
| 2023-12-12 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-08-08 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-23 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2023-05-09 | Herabstufung | Goldman | Buy → Neutral |
| 2023-01-05 | Herabstufung | UBS | Buy → Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-11-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Eingeleitet | BofA Securities | Buy |
| 2020-12-15 | Eingeleitet | Credit Suisse | Outperform |
| 2020-12-15 | Eingeleitet | Goldman | Buy |
| 2020-12-15 | Eingeleitet | Jefferies | Buy |
| 2020-12-15 | Eingeleitet | Robert W. Baird | Outperform |
| 2020-12-15 | Eingeleitet | Stifel | Buy |
| 2020-12-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-14 | Eingeleitet | UBS | Buy |
Alle ansehen
Maravai Lifesciences Holdings Inc Aktie (MRVI) Neueste Nachrichten
Why Should We Buy Maravai LifeSciences Holdings Inc (MRVI) Stock? - Marketing Sentinel
Levi & Korsinsky Notifies Shareholders of Maravai LifeSciences Holdings, Inc.(MRVI) of a ... - Bluefield Daily Telegraph
Levi & Korsinsky Notifies Shareholders of Maravai - GlobeNewswire
Levi & Korsinsky Notifies Shareholders of Maravai LifeSciences Holdings, Inc.(MRVI) of a Class Action Lawsuit and an Upcoming Deadline - GlobeNewswire Inc.
MRVI’s latest rating updates from top analysts. - knoxdaily.com
MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GuruFocus
Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class Action – Hagens Berman - GlobeNewswire
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
The Gross Law Firm Reminds Maravai LifeSciences Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025MRVI - GuruFocus
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Brokerages - Defense World
Maravai LifeSciences Holdings, Inc. (MRVI) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds MRVI Investors of Securities Fraud Class Action Lawsuit - PR Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit - GuruFocus
MRVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors - Bluefield Daily Telegraph
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - GlobeNewswire
Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMRVI - The Malaysian Reserve
2025-04-18 | Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences Holdings, Inc. LawsuitMRVI | NDAQ:MRVI | Press Release - Stockhouse
DEADLINE ALERT for SWKS, MRVI, APP, and RC: The Law Offices - GlobeNewswire
Deadline Alert: Maravai LifeSciences Holdings, Inc. (MRVI) - GlobeNewswire
2025-04-18 | Faruqi & Faruqi Reminds Maravai LifeSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025MRVI | NDAQ:MRVI | Press Release - Stockhouse
ROSEN, A LEADING LAW FIRM, Encourages Maravai Lifesciences Holdings, Inc. Investors to Secure - Bluefield Daily Telegraph
Maravai LifeSciences (MRVI) Reports Weak Q4, Faces Investor Class ActionHagens Berman - TradingView
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 5, 2025 in Maravai LifeSciences Holdings, Inc. Lawsuit – MRVI - TradingView
Maravai LifeSciences Holdings, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before May 5, 2025 to Discuss Your RightsMRVI - MarketScreener
Kirby McInerney LLP Urges Investors in Maravai Lifesciences Holdings, Inc. to Inquire About Their Rights in Class Action Lawsuit - Business Wire
Maravai LifeSciences (MRVI) Earnings Call Raises Questions Amid Legal Allegations – Hagens Berman - GlobeNewswire
MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
MRVI Investors Have the Opportunity to Lead the Maravai - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
Maravai LifeSciences Holdings, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - PR Newswire
The Gross Law Firm Notifies Shareholders of Maravai - GlobeNewswire
The Gross Law Firm Notifies Shareholders of Maravai LifeSciences Holdings, Inc. (MRVI) of a Class Action Lawsuit and an Upcoming Deadline - TradingView
Maravai Lifesciences stock hits 52-week low at $1.72 By Investing.com - Investing.com India
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - Morningstar
Maravai Lifesciences stock hits 52-week low at $1.72 - Investing.com
MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsMRVI - PR Newswire
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Maravai Lifesciences Holdings, Inc. Investors to - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming DeadlinesMRVI - PR Newswire
Lowey Dannenberg Notifies Maravai LifeSciences Holdings, - GlobeNewswire
Shareholders That Lost Money on Maravai LifeSciences Holdings, Inc. (MRVI) Should Contact Levi & Korsinsky About Pending Class ActionMRVI - ACCESS Newswire
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)May 5, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - TradingView
MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
MRVI Investors Have the Opportunity to Lead the Maravai LifeSciences Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
Vanguard Group Inc. Has $64.43 Million Stock Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Levi & Korsinsky Reminds Maravai LifeSciences Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025MRVI - ACCESS Newswire
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Maravai - GlobeNewswire
MRVI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
Finanzdaten der Maravai Lifesciences Holdings Inc-Aktie (MRVI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
4.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):